- Home
- CTLP vs OCS Comparison
CTLP vs OCS Comparison
Compare CTLP & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTLP
- OCS
- Stock Information
- Founded
- CTLP 1992
- OCS 2003
- Country
- CTLP United States
- OCS Switzerland
- Employees
- CTLP N/A
- OCS N/A
- Industry
- CTLP EDP Services
- OCS Biotechnology: Pharmaceutical Preparations
- Sector
- CTLP Technology
- OCS Health Care
- Exchange
- CTLP Nasdaq
- OCS Nasdaq
- Market Cap
- CTLP 797.4M
- OCS 956.4M
- IPO Year
- CTLP N/A
- OCS N/A
- Fundamental
- Price
- CTLP $10.87
- OCS $16.13
- Analyst Decision
- CTLP Hold
- OCS Strong Buy
- Analyst Count
- CTLP 5
- OCS 4
- Target Price
- CTLP $11.50
- OCS $35.75
- AVG Volume (30 Days)
- CTLP 1.9M
- OCS 10.0K
- Earning Date
- CTLP 09-10-2025
- OCS 08-21-2025
- Dividend Yield
- CTLP N/A
- OCS N/A
- EPS Growth
- CTLP 404.65
- OCS N/A
- EPS
- CTLP 0.80
- OCS N/A
- Revenue
- CTLP $292,642,000.00
- OCS $960,668.00
- Revenue This Year
- CTLP $15.44
- OCS $11.49
- Revenue Next Year
- CTLP $15.82
- OCS $1,784.02
- P/E Ratio
- CTLP $13.58
- OCS N/A
- Revenue Growth
- CTLP 12.51
- OCS N/A
- 52 Week Low
- CTLP $5.82
- OCS $11.56
- 52 Week High
- CTLP $11.36
- OCS $23.08
- Technical
- Relative Strength Index (RSI)
- CTLP 46.97
- OCS 25.10
- Support Level
- CTLP $10.83
- OCS $17.51
- Resistance Level
- CTLP $10.88
- OCS $18.23
- Average True Range (ATR)
- CTLP 0.06
- OCS 0.40
- MACD
- CTLP -0.02
- OCS -0.16
- Stochastic Oscillator
- CTLP 38.10
- OCS 2.42
About CTLP Cantaloupe Inc.
Cantaloupe Inc operates in the small ticket electronic payments industry. It provides wireless, cashless, micro-transactions, and networking services within the unattended Point of Sale (POS) market. Its products and services portfolio consists of ePort Cashless devices, eSuds, EnergyMisers, and Value-added services which include Loyalty and Prepaid, Intelligent Vending, and others. The company offers services to different industries covering car wash, taxi and transportation, laundry, vending, kiosk, amusement, and arcade. The company derives revenue from the sale or lease of equipment and services to the small ticket, unattended POS market, and the majority of its revenue is derived from subscription and transaction fees.
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.